A Study to Evaluate ALN-AGT01 RVR in Adult Healthy Volunteers

Clinical trial NCT06675565 · COMPLETED

Trial details

NCT number: NCT06675565
Sponsor: Alnylam Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2024-11-05
Primary completion: 2025-09-08
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.